Oral Semaglutide
GLP-1 Support Without Needles
Daily oral option for patients who want appetite and craving support—guided by a licensed provider.
- In a 68-week obesity trial, participants taking high-dose oral semaglutide had an average ~15% body-weight reduction vs ~2% with placebo.
- In type 2 diabetes trials, oral semaglutide improved A1C and reduced weight vs placebo (dose-dependent).
- Oral semaglutide (Rybelsus) is FDA-approved for type 2 diabetes; dosing requires taking on an empty stomach.
Start In Minutes
- 2–3 Minute Intake
- Checkout
- Provider Review → Ships If Approved
$199/month all-inclusive • Cancel anytime
Ships within ~1 week after approval • Autoships monthly
What Oral Semaglutide Helps You Do
Semaglutide is a GLP-1 receptor agonist. In practice, GLP-1 support helps many patients feel full sooner, reduce cravings, and eat smaller portions more comfortably—making adherence easier.”
Appetite Control
Fullness sooner, less grazing.
Craving Reduction
Less ‘food noise’ for many.
Consistency
Better week-to-week adherence.
Outcomes vary, but in clinical trials, higher-dose oral semaglutide produced substantial average weight reductions over time.
What Results Can Look Like
Typical experiences depend on adherence, dosing, and individual factors.
Obesity Trial (68 weeks)
Average ~15.1% body-weight reduction with oral semaglutide 50 mg vs ~2.4% with placebo.
High Responder Signal
A large proportion achieved ≥5% weight loss in the same trial.
Type 2 Diabetes Trial
Oral semaglutide improved glycemic control and showed weight loss benefits (strongest at 14 mg vs placebo).
Many patients notice appetite changes early; visible weight change is often more apparent over weeks to months with consistent nutrition and routine.
Clinical Evidence (Why This Isn’t Hype)
Obesity / Overweight
- In a randomized trial in adults with obesity/overweight, oral semaglutide 50 mg produced a mean weight change of −15.1% at 68 weeks vs −2.4% with placebo.
- This supports oral semaglutide as a serious option for needle-averse patients who prefer daily dosing.
Type 2 Diabetes
- Oral semaglutide improved A1C and reduced weight versus placebo in T2D trials (dose-dependent), including PIONEER 1.
FDA-labeled Dosing Behavior
- Oral semaglutide tablets must be taken as directed (empty stomach + timing) to optimize absorption.
FDA has raised concerns about compounding certain bulk substances including BPC-157 and notes limited safety information for proposed routes of administration.
Who Oral Semaglutide Is Best For
- You want GLP-1 support but prefer no injections.
- You want appetite/craving support to improve consistency.
- You can commit to a daily routine (best outcomes come from adherence
- You want an all-inclusive program—no surprise fees.
Not everyone qualifies. Provider review confirms eligibility.
How to Start (Fast + Provider-Guided)
Online intake (2–3 minutes)
Checkout
Provider Review
Ships After Approval
Typically within ~1 week; autoships monthly so you don’t run out
$199/Month - All Inclusive
No add-ons. No surprise fees
What’s included
- Doctor consultation review
- Prescribing medication
- Cost of medication
- Shipping to door
- Ongoing support from doctor
- Patient portal access
Ships within ~1 week of approval • Autoships monthly • Cancel anytime
Support That Helps You Stay Consistent
Provider-guided plan
Portal access (refills, updates)
Ongoing support + autoship
You have questions? Get the results
Within ~1 week after approval
Yes
Yes
Varies; reference clinical results as context
Follow provider direction; empty stomach/timing
Ready to Start Without Needles?
Check eligibility in minutes. Provider review required.
• Autoships monthly • Cancel anytime
Oral Semaglutide
GLP-1 Support Without Needles
Daily oral option for patients who want appetite and craving support—guided by a licensed provider.
- In a 68-week obesity trial, participants taking high-dose oral semaglutide had an average ~15% body-weight reduction vs ~2% with placebo.
- In type 2 diabetes trials, oral semaglutide improved A1C and reduced weight vs placebo (dose-dependent).
- Oral semaglutide (Rybelsus) is FDA-approved for type 2 diabetes; dosing requires taking on an empty stomach.
Start In Minutes
- 2–3 Minute Intake
- Checkout
- Provider Review → Ships If Approved
$199/month all-inclusive • Cancel anytime
Ships within ~1 week after approval • Autoships monthly